These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30325775)

  • 1. Sexual intermingling of Arab and Jewish MSM in Israel: results of a molecular epidemiology study.
    Zuckerman NS; Mor Z; Bucris E; Wax M; Mendelson E; Mor O
    AIDS; 2019 Feb; 33(2):339-344. PubMed ID: 30325775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arab men who have sex with men in Israel: knowledge, attitudes and sexual practices.
    Mor Z; Grayeb E; Beany A
    HIV Med; 2016 Apr; 17(4):298-304. PubMed ID: 26347347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naïve Individuals in Israel, 2010-2018.
    Wagner T; Zuckerman NS; Halperin T; Chemtob D; Levy I; Elbirt D; Shachar E; Olshtain-Pops K; Elinav H; Chowers M; Itsomin V; Riesenberg K; Wax M; Shirazi R; Gozlan Y; Matus N; Girshengorn S; Marom R; Mendelson E; Turner D; Mor O
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.
    Grgic I; Lepej SZ; Lunar MM; Poljak M; Vince A; Vrakela IB; Planinic A; Seme K; Begovac J
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):329-36. PubMed ID: 22906365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between next-generation and Sanger-based sequencing for the detection of transmitted drug-resistance mutations among recently infected HIV-1 patients in Israel, 2000-2014.
    Moscona R; Ram D; Wax M; Bucris E; Levy I; Mendelson E; Mor O
    J Int AIDS Soc; 2017 Aug; 20(1):21846. PubMed ID: 28799325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing trend of HIV/AIDS among Arab and Jewish male persons in Israel, 1986-2010.
    Mor Z; Grayeb E; Beany A; Grotto I
    HIV Med; 2013 May; 14(5):316-20. PubMed ID: 23173994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission dynamics of HIV-1 subtype B in the Basque Country, Spain.
    Patiño-Galindo JA; Thomson MM; Pérez-Álvarez L; Delgado E; Cuevas MT; Fernández-García A; Nájera R; Iribarren JA; Cilla G; López-Soria L; Lezaun MJ; Cisterna R; González-Candelas F;
    Infect Genet Evol; 2016 Jun; 40():91-97. PubMed ID: 26921800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
    Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 infection among women in Israel, 2010-2018.
    Wagner T; Olshtain-Pops K; Wax M; Horwitz O; Shirazi R; Gozlan Y; Volnowitz H; Mendelson E; Levy I; Mor O
    BMC Infect Dis; 2020 Sep; 20(1):660. PubMed ID: 32894102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Prevalence of Sequences Included in Transmission Clusters Within Newly Diagnosed HIV-1 Patients in Southern Spain (2004-2015).
    González-Domenech CM; Sena-Corrales G; Viciana-Ramos I; Palacios-Muñoz R; Mora-Navas L; Clavijo-Frutos E; Santos-González J
    Microb Drug Resist; 2020 Sep; 26(9):1090-1097. PubMed ID: 32240038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Genetic Diversity and Transmitted Drug Resistance in Antiretroviral Treatment-Naive Individuals from Amapá State, Northern Brazil.
    Dos Anjos Silva L; Divino F; da Silva Rêgo MO; Lima Lopes IG; Nóbrega Costa CM; da Silva Pereira FC; de Filippis I; Bello G
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):373-6. PubMed ID: 26529282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14.
    Fabeni L; Alteri C; Di Carlo D; Orchi N; Carioti L; Bertoli A; Gori C; Forbici F; Continenza F; Maffongelli G; Pinnetti C; Vergori A; Mondi A; Ammassari A; Borghi V; Giuliani M; De Carli G; Pittalis S; Grisetti S; Pennica A; Mastroianni CM; Montella F; Cristaudo A; Mussini C; Girardi E; Andreoni M; Antinori A; Ceccherini-Silberstein F; Perno CF; Santoro MM; ;
    J Antimicrob Chemother; 2017 Oct; 72(10):2837-2845. PubMed ID: 29091206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS; Cardoso LP; Stefani MM
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low rate of transmitted drug resistance may indicate low access to antiretroviral treatment in Maranhão State, northeast Brazil.
    Moura ME; Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):250-4. PubMed ID: 25411830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.
    Pingen M; Wensing AM; Fransen K; De Bel A; de Jong D; Hoepelman AI; Magiorkinis E; Paraskevis D; Lunar MM; Poljak M; Nijhuis M; Boucher CA;
    Retrovirology; 2014 Nov; 11():105. PubMed ID: 25575025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phylogenetic Investigation of a Statewide HIV-1 Epidemic Reveals Ongoing and Active Transmission Networks Among Men Who Have Sex With Men.
    Chan PA; Hogan JW; Huang A; DeLong A; Salemi M; Mayer KH; Kantor R
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):428-35. PubMed ID: 26258569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
    Frange P; Assoumou L; Descamps D; Chéret A; Goujard C; Tran L; Gousset M; Avettand-Fenoël V; Bocket L; Fafi-Kremer S; Guinard J; Morand-Joubert L; Nicot F; Plantier JC; Rogez S; Wirden M; Rouzioux C; Meyer L; Chaix ML; ;
    J Antimicrob Chemother; 2015 Jul; 70(7):2084-9. PubMed ID: 25885327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Trends in Western Australian HIV-1 Sequence Diversity and Viral Transmission Networks and Their Influence on Clinical Parameters: 2000-2014.
    Castley AS; Gaudieri S; James I; Gizzarelli LS; Guelfi G; John M; Nolan D
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):211-9. PubMed ID: 26530340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations.
    Vega Y; Delgado E; Fernández-García A; Cuevas MT; Thomson MM; Montero V; Sánchez M; Sánchez AM; Pérez-Álvarez L;
    PLoS One; 2015; 10(5):e0125699. PubMed ID: 26010948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC; Rocco CA; Mecikovsky D; Bologna R; Mangano A; Sen L
    Antivir Ther; 2010; 15(4):641-50. PubMed ID: 20587857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.